Literature DB >> 26768314

Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.

Matthew T Siedhoff1, Kenneth H Kim2.   

Abstract

Minimally invasive surgery (MIS) is increasingly being used to treat uterine fibroids because of the significant patient and societal benefits of these techniques over traditional laparotomy. Morcellation affords the removal of large fibroids in MIS but carries the risk of disseminating occult malignant tissue. The benefits of MIS for treating fibroids must be carefully weighed against its risks of morcellation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  fibroids; hysterectomy; leiomyosarcoma; morcellation; myomectomy

Mesh：

Year:  2015        PMID： 26768314     DOI： 10.1002/jso.24010

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  3 in total

1.  Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

Authors:  Jeong Yeol Park; Jeong Won Lee; Hyun Ju Lee; Jong Jin Lee; Seung Hwan Moon; Seo Young Kang; Gi Jeong Cheon; Hyun Hoon Chung
Journal:  J Gynecol Oncol       Date:  2017-02-02       Impact factor: 4.401

2.  Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases.

Authors:  Lanqing Huo; Dan Wang; Wenze Wang; Dongyan Cao; Jiaxin Yang; Ming Wu; Junjun Yang; Yang Xiang
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

3.  Preoperative MRI and LDH in women undergoing intra-abdominal surgery for fibroids: Effect on surgical route.

Authors:  Annie Kim; Leslie Boyd; Nancy Ringel; Jessica Meyer; Genevieve Bennett; Veronica Lerner
Journal:  PLoS One       Date:  2021-02-09       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.